Welcome to LookChem.com Sign In|Join Free

CAS

  • or

111097-54-2

Post Buying Request

111097-54-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111097-54-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 111097-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,0,9 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 111097-54:
(8*1)+(7*1)+(6*1)+(5*0)+(4*9)+(3*7)+(2*5)+(1*4)=92
92 % 10 = 2
So 111097-54-2 is a valid CAS Registry Number.

111097-54-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(3-Butyn-1-yl)-2-pyrimidinamine

1.2 Other means of identification

Product number -
Other names 2-(3-butynyl)-3,4-hexadien-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111097-54-2 SDS

111097-54-2Relevant articles and documents

Novel triazole derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating Aurora Kinase relating diseases containing the same as an active ingredient

-

Paragraph 0177, (2017/08/02)

The present invention relates to a novel triazole derivative, a production method thereof, and an aurora kinase-associated pharmaceutical composition containing the same as an active ingredient. According to the present invention, the novel triazole derivative, an optical isomer thereof, or a pharmaceutically acceptable salt thereof exhibits excellent inhibitory activities as aurora kinase at nanomolar scale, thereby showing effectiveness in the treatment of various types of cancer or tumor as the pharmaceutical composition containing the same.COPYRIGHT KIPO 2017

RING-TRANSFORMATIONS OF PYRIMIDINES BY INTRAMOLECULAR DIELS-ALDER REACTIONS. SYNTHESIS OF ANNELATED PYRIDINES

Frissen, A. E.,Marcelis, A. T. M.,Plas, H. C. van der

, p. 803 - 812 (2007/10/02)

Pyrimidines carrying an ω-alkyne side-chain -XCH2CH2CCH (X=O,N,S,SO,SO2) at the 2 or 5 position undergo intramolecular inverse electron demand Diels-Alder reactions across the C-2 and C-5 positions; elimination of hydrogen (or alkyl) cyanide from the intermediate adducts leads to condensed pyridines.The influence of the hetero atom (X) in the dienophilic side-chain and that of substituents in the pyrimidine ring on the reactivity is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 111097-54-2